Following the recently announced divestment of Venture Life’s contract development and manufacturing organisation (CDMO) businesses, Venture Life will become a focused pure play consumer health business. The company aims to be a meaningful player in the global consumer healthcare sector, which is valued at c$300bn and expected to grow at high single-digit growth rates in the near term. While the market reacted positively to the announcement, on a post-sale basis we believe Venture Life will stil ....
